1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6D072E51B6FB0872465257D0A00456DD4
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-preparing-medical-science-liaison-teams-for-a-changing-environment-value-and-budget?opendocument
18
19opendocument
2018.212.222.217
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Science Liaison

Preparing Medical Science Liaison Teams for a Changing Environment: Value and Budget

ID: 5313


Features:

11 Info Graphics

13 Data Graphics

168 Metrics


Pages/Slides: 31


Published: 2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from "Preparing Medical Science Liaison Teams for a Changing Environment: Value and Budget"


STUDY OVERVIEW

Their interactions with thought leaders have made Medical Science Liaisons an important part of biopharmaceutical companies' clinical programs. Best Practices, LLC conducted this benchmarking study to provide leading insights on the value associated with MSLs’ responsibilities and how MSL team budgets are allocated. This study captures wide-ranging insights and metrics that will help Medical Affairs leaders to demonstrate the value of their MSL teams and to compare their budget allocations with peers in the industry. Companies can use this study to improve the effectiveness of their Medical Science Liaison teams.

KEY TOPICS

  • Medical Liaisons: Leadership and Value
  • Medical Liaisons: Resources and Budget

SAMPLE KEY METRICS
  • Medical science liaisons leadership
  • Value associated with Medical science liaison responsibilities for mature and emerging markets
  • Level of outsourcing at MSL teams
  • Factors affecting annual MSL team budgets
  • Breakdown of MSL team budget at mature and emerging markets

SAMPLE KEY FINDING

Value Associated with Medical Science Liaisons’ Responsibilities: Internal stakeholders find value in responsibilities related to medical communication with key influencers and internal support for sales & marketing activities. While perceived value for medical communication with external stakeholders is seen as high, there is less perceived value for the internal support for sales & marketing among internal stakeholders.

METHODOLOGY

This study engaged executives from 32 leading healthcare companies. Segmentation analysis was key to examining trends and effective practices. Twenty three participants make up the Mature Markets Segment, while the Emerging Markets Segment consists of seven participants from Brazil, India and other Asia markets. This report includes Mature and Emerging Markets segments’ analysis.

Industries Profiled:
Biotech; Health Care; Pharmaceutical; Biopharmaceutical; Clinical Research; Laboratories; Chemical; Medical Device


Companies Profiled:
Acorda Therapeutics; United Therapeutics; Sanofi; Upsher-Smith; Kadmon Pharmaceuticals; Shire; Crescendo Bioscience; Teva Pharmaceutical Industries Ltd; Lilly; Baxter BioScience; Merck; Cubist Pharmaceuticals; Pierre Fabre Medicament; Amgen; ProStrakan; Dr Reddy's Laboratories; Biocon; Genentech; Astellas; Ironwood; Biogen Idec; AstraZeneca; Covidien


If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.